RICH
MCID: RPD005
MIFTS: 38

Rapidly Involuting Congenital Hemangioma (RICH)

Categories: Cardiovascular diseases, Fetal diseases, Rare diseases

Aliases & Classifications for Rapidly Involuting Congenital Hemangioma

MalaCards integrated aliases for Rapidly Involuting Congenital Hemangioma:

Name: Rapidly Involuting Congenital Hemangioma 59
Rich 59

Characteristics:

Orphanet epidemiological data:

59
rapidly involuting congenital hemangioma
Inheritance: Not applicable; Age of onset: Infancy,Neonatal;

Classifications:



External Ids:

ICD10 via Orphanet 34 D18.0
UMLS via Orphanet 73 C1275421
Orphanet 59 ORPHA141184

Summaries for Rapidly Involuting Congenital Hemangioma

MalaCards based summary : Rapidly Involuting Congenital Hemangioma, also known as rich, is related to congenital hemangioma and hemangioma. The drugs Insulin Aspart and Parathyroid hormone have been mentioned in the context of this disorder. Affiliated tissues include bone, liver and endothelial, and related phenotypes are telangiectasia of the skin and subcutaneous calcification

Wikipedia : 75 A Rapidly involuting congenital hemangioma is a cutaneous condition characterized by a fully developed... more...

Related Diseases for Rapidly Involuting Congenital Hemangioma

Diseases related to Rapidly Involuting Congenital Hemangioma via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 18)
# Related Disease Score Top Affiliating Genes
1 congenital hemangioma 11.9
2 hemangioma 10.8
3 non-involuting congenital hemangioma 10.5
4 arteriovenous malformation 10.2
5 thrombocytopenia 10.2
6 posttransplant acute limbic encephalitis 10.2
7 rare tumor 10.2
8 angioma, tufted 10.1
9 deficiency anemia 10.1
10 telangiectasis 10.1
11 vascular cancer 10.1
12 teratoma 10.1
13 fibrosarcoma 10.1
14 congenital fibrosarcoma 10.1
15 cleft lip 10.1
16 hemangioendothelioma 10.1
17 kaposiform hemangioendothelioma 10.1
18 rare vascular tumor 10.1

Graphical network of the top 20 diseases related to Rapidly Involuting Congenital Hemangioma:



Diseases related to Rapidly Involuting Congenital Hemangioma

Symptoms & Phenotypes for Rapidly Involuting Congenital Hemangioma

Human phenotypes related to Rapidly Involuting Congenital Hemangioma:

59 32 (show all 15)
# Description HPO Frequency Orphanet Frequency HPO Source Accession
1 telangiectasia of the skin 59 32 frequent (33%) Frequent (79-30%) HP:0100585
2 subcutaneous calcification 59 32 frequent (33%) Frequent (79-30%) HP:0007618
3 midfrontal capillary hemangioma 59 32 frequent (33%) Frequent (79-30%) HP:0007466
4 perineal hemangioma 59 32 frequent (33%) Frequent (79-30%) HP:0031449
5 congestive heart failure 59 32 occasional (7.5%) Occasional (29-5%) HP:0001635
6 thrombocytopenia 59 32 occasional (7.5%) Occasional (29-5%) HP:0001873
7 peripheral arteriovenous fistula 59 32 occasional (7.5%) Occasional (29-5%) HP:0100784
8 prominent superficial veins 59 32 occasional (7.5%) Occasional (29-5%) HP:0001015
9 lipoatrophy 59 32 very rare (1%) Very rare (<4-1%) HP:0100578
10 hepatic hemangioma 59 32 very rare (1%) Very rare (<4-1%) HP:0031207
11 avascular necrosis 32 very rare (1%) HP:0010885
12 aseptic necrosis 59 Very rare (<4-1%)
13 hemangioma 59 Obligate (100%)
14 visceral hemangioma 59 Occasional (29-5%)
15 tufted angioma 59 Excluded (0%)

Drugs & Therapeutics for Rapidly Involuting Congenital Hemangioma

Drugs for Rapidly Involuting Congenital Hemangioma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 990)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Insulin Aspart Approved Phase 4 116094-23-6 16132418
2
Parathyroid hormone Approved, Investigational Phase 4 9002-64-6
3
Asenapine Approved Phase 4 65576-45-6, 85650-56-2 3001386
4
Lactulose Approved Phase 4 4618-18-2 11333
5
Insulin glulisine Approved Phase 4 207748-29-6
6
Insulin Lispro Approved Phase 4 133107-64-9
7
Linagliptin Approved Phase 4 668270-12-0 10096344
8
Citalopram Approved Phase 4 59729-33-8 2771
9
Cimetidine Approved, Investigational Phase 4 51481-61-9 2756
10
leucovorin Approved Phase 4 58-05-9 143 6006
11
Simvastatin Approved Phase 4 79902-63-9 54454
12
Nicotinamide Approved, Investigational Phase 4 98-92-0 936
13
Iron Approved, Experimental Phase 4 15438-31-0, 7439-89-6 23925 27284
14
Acetaminophen Approved Phase 4 103-90-2 1983
15
Magnesium citrate Approved Phase 4 3344-18-1
16
Potassium Citrate Approved, Investigational, Vet_approved Phase 4
17 Artichoke Approved Phase 4
18
Dimenhydrinate Approved Phase 4 523-87-5 441281
19
Ezetimibe Approved Phase 4 163222-33-1 150311
20
Metronidazole Approved Phase 4 443-48-1 4173
21
Palonosetron Approved, Investigational Phase 4 119904-90-4, 135729-61-2, 135729-56-5 148211
22
Flurbiprofen Approved, Investigational Phase 4 5104-49-4 3394
23
Pentazocine Approved, Vet_approved Phase 4 359-83-1 441278
24
Vildagliptin Approved, Investigational Phase 4 274901-16-5 6918537
25
Ciprofloxacin Approved, Investigational Phase 4 85721-33-1 2764
26
Lixisenatide Approved Phase 4 320367-13-3
27
Amodiaquine Approved, Investigational Phase 4 86-42-0 2165
28
Ribavirin Approved Phase 4 36791-04-5 37542
29
Peginterferon alfa-2b Approved Phase 4 99210-65-8, 215647-85-1
30
Allopurinol Approved Phase 4 315-30-0 2094
31
Histamine Approved, Investigational Phase 4 51-45-6 774
32
Neomycin Approved, Vet_approved Phase 4 1404-04-2 8378
33
Polymyxin B Approved, Vet_approved Phase 4 1404-26-8
34
Bacitracin Approved, Vet_approved Phase 4 1405-87-4 439542 10909430
35
Ferrous succinate Approved Phase 4 10030-90-7
36
Xylometazoline Approved, Investigational Phase 4 526-36-3 5709
37
Glimepiride Approved Phase 4 93479-97-1 3476
38
Cilostazol Approved, Investigational Phase 4 73963-72-1 2754
39
Sulfadoxine Approved, Investigational Phase 4 2447-57-6 17134
40
Pyrimethamine Approved, Investigational, Vet_approved Phase 4 58-14-0 4993
41
Hyaluronic acid Approved, Vet_approved Phase 4 9004-61-9 53477741
42
Atorvastatin Approved Phase 4 134523-00-5 60823
43
Sargramostim Approved, Investigational Phase 4 83869-56-1, 123774-72-1
44
Lenograstim Approved, Investigational Phase 4 135968-09-1
45
Amoxicillin Approved, Vet_approved Phase 4 26787-78-0 33613
46
Mannitol Approved, Investigational Phase 4 69-65-8 453 6251
47
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 4 437-38-7 3345
48
Guaifenesin Approved, Investigational, Vet_approved Phase 4 93-14-1 3516
49
Probucol Approved, Investigational Phase 4 23288-49-5 4912
50
Ketamine Approved, Vet_approved Phase 4 6740-88-1 3821

Interventional clinical trials:

(show top 50) (show all 2748)
# Name Status NCT ID Phase Drugs
1 Efficacy of Intra-articular Injection of Combined Hyaluronic Acid and Platelet-rich Plasma in Knee Degenerative Joint Disease Unknown status NCT03211650 Phase 4 hyaluronic Acid + platelet-rich plasma;hyaluronic acid;platelet-rich plasma
2 Evaluation of Platelet Rich Fibrin Efficacy on Reduction of Periodontal Problems Unknown status NCT01583491 Phase 4
3 The Effect of Using Autologous Platelet Rich Plasma on Posterior Lumbar Interbody Fusion : a Randomized Comparative Trial Unknown status NCT03261843 Phase 4
4 Evaluating the Efficacy of Different Platelet Rich Plasma (PRP) Treatment Regimens in the Management of Androgenetic Alopecia: an Investigator-initiated, Single-center, Single-blinded, Prospective, Randomized Clinical Trial Unknown status NCT02999737 Phase 4
5 A 104-week, Open-label, Single-group Study: Rosuvastatin Evaluation of Atherosclerotic Chinese Patients (REACH) Unknown status NCT00885872 Phase 4 Rosuvastatin (Crestor)
6 Platelet Rich Fibrin in the Treatment of Palatal Wounds After Epithelialized Free Gingival Grafts Harvesting. A Randomized Clinical Trial Unknown status NCT02438046 Phase 4
7 Does Varying the Chloride Content of Intravenous Fluid Alter the Risk of Acute Kidney Injury After Cardiac Surgery? Unknown status NCT02020538 Phase 4
8 Omega-3 Fatty Acids in First-episode Schizophrenia - a Randomized Controlled Study of Efficacy and Relapse Prevention (OFFER). Rationale, Design, and Methods. Unknown status NCT02210962 Phase 4
9 Low Dose Calcium Supplementation to Prevent Preeclampsia: a Cluster Randomized Study Unknown status NCT02338687 Phase 4
10 An Open-label Switch Study to Asenapine in the Early Stage of Psychosis Unknown status NCT01968161 Phase 4 Asenapine
11 Comparative Study About the Impact of Two Oil Emulsions, One of Them Formulated With MCT, LCT, Olive Oil and Omega 3 Fatty Acids Versus Another One Formulated With MCT and LCT, Administered Intravenously on Severe Acute Pancreatitis Clinical Evolution Unknown status NCT01376817 Phase 4 Fat emulsion with MCT, LCT, olive oil and omega 3 fatty acids;Fat emulsion with MCT and LCT
12 Randomized Clinical Trial of Omega-3 Fatty Acid-supplemented Parenteral Nutrition Versus Standard Parenteral Nutrition in Patients Undergoing Major Laparoscopic Abdominal Surgery Unknown status NCT01819961 Phase 4 MCT/LCT and fish oil;MCT/LCT
13 Effects of Fenofibrate on Endothelial Progenitor Cell Levels in Diabetic Patients With Retinopathy. A Randomized Controlled Trial. Unknown status NCT01927315 Phase 4 Fenofibrate 145 mg;Placebo
14 Delayed Vasospasm After Aneurysm With the Standardization Treatment of Traditional Chinese Medicine Unknown status NCT01840761 Phase 4 herbal drug;placebo
15 Effect of Multi-vitamins With Minerals on Uric Acid Metabolism in Subjects With Hyperuricemia: A Randomized, Double-blinded, Placebo-controlled Trail Unknown status NCT03218709 Phase 4
16 Adjusted Steroid Therapy in Children With Idiopathic Nephrotic Syndrome Unknown status NCT02649413 Phase 4 Prednisone
17 Phase 4 Study of Vitamin D3 Supplementation for Outcomes in Patients With Unipolar Depression Unknown status NCT01390662 Phase 4
18 Treatment of Plantar Fasciitis With Injection af Platelet-rich Plasma Into the Origin of the Plantar Fascia - a Prospective, Randomized and Double Blinded Study. Unknown status NCT01509274 Phase 4
19 Insulin Requirement for Pure- Protein Meal in Children With Type 1 Diabetes Treated With Continuous Subcutaneous Insulin Infusion - a Cross-over, Randomized Trial. Unknown status NCT02685449 Phase 4 Insulin glulisine;Insulin aspart;Insulin lispro
20 Effect of Linagliptin on Intestinal Triglyceride-rich-lipoprotein Metabolism in Type 2 Diabetic Patients Unknown status NCT02280174 Phase 4 linagliptin
21 Prostatic Artery Embolization Versus 532 nm Green Light Laser Photoselective Vaporization of the Prostate for Treating Catheter-Dependent Patients With Benign Prostatic Hyperplasia: A Randomized Controlled Clinical Study Unknown status NCT02006303 Phase 4
22 Pre-hYpertension tReament With A coMbinatIon of Dietary Supplements and Life-style Modifications Unknown status NCT01682291 Phase 4
23 Advancing Personalized Antidepressant Treatment Using PET/MRI Unknown status NCT02623205 Phase 4 Escitalopram;Placebo
24 Effects of a Chronical Treatment With Benfotiamine in People With Type 2 Diabetes Mellitus on Pre- and Postprandial Endothelial Function, as Well as on the Function of the Autonomic Nervous System Unknown status NCT00446810 Phase 4 Benfotiamine;Placebo
25 Artemether/ Lumefantrine: A Study of the Effect of Local Food on Pharmacokinetics of Lumefantrine and Population Pharmacokinetics of Lumefantrine Among Ugandan Children Unknown status NCT01944189 Phase 4
26 Effect of Rosuvastatin Therapy on HDL2 Level and Antiatherosclerotic Reverse Cholesterol Transport Process in Chinses CAD Patients With Hyperlipidemia Unknown status NCT02593487 Phase 4 Rosuvastatin 10mg/d group;Rosuvastatin 20mg/d group
27 Fixed-dose vs. Phenotype-based PrAsugrel Dose to MATCH Therapeutic Zone in Asians With Acute Coronary Syndrome Unknown status NCT01951001 Phase 4 Prasugrel
28 Effect of Iron Supplementation on Psychomotor Development of Non-anemic Exclusively or Predominantly Breastfed Infants: Randomized, Double-blind, Placebo-controlled Trial. Unknown status NCT02242188 Phase 4 Iron
29 Multicenter Study Evaluating the Efficacy of Dicopeg Junior in Comparison With Lactulose for the Treatment of Functional Constipation in Children Aged 6 Months to 6 Years. A Prospective, Randomized Study. Unknown status NCT03177434 Phase 4 polyethylene glycols (PEG) 3350;Lactulose Oral Product
30 A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF THE SUPPLEMENTATION WITH KIOLIC® IN PATIENTS WITH DIAGNOSIS OF METABOLIC SYNDROME TO IMPROVE ENDOTHELIAL FUNCTION AND INFLAMMATORY STATE. "KYMES" Unknown status NCT01168700 Phase 4 aged garlic extract;Placebo
31 The ACT-OUT Trial: ACTivity OUTcomes Based on the Consumption of a High Carbohydrate or High Fat Diet in Patients With Metabolic Syndrome Unknown status NCT01357382 Phase 4
32 Effect of Platelet Rich Plasma ( PRP ) Applied During Knee Arthroscopy on Pain, Function and Quality of Life - A RCT With a Follow up of 12 Months Completed NCT02189408 Phase 4
33 Platelet Rich Plasma (PRP) in Total Knee Replacement: A Prospective, Randomized, Single-blind, Single-center Clinical Study to Evaluate the Effect of Platelet Rich Plasma (PRP) on Short-term Patient Outcomes Following Total Knee Replacement Completed NCT00826098 Phase 4
34 A Prospective Study to Analyze the Efficacy of IgM Rich Immunoglobulin as an Adjunct to Antibiotics in the Treatment of Bacterial Sepsis in Very Low Birth Weight Preterm Neonates Completed NCT03403530 Phase 4 IgM rich Immunoglobin
35 Impact of Short-term Fructose-enriched Diet on Serum Metabolome by Normal- and Over-weighed Women. Completed NCT03444233 Phase 4
36 Socket Augmentation Using Different Platelet Concentrates, Atorvastatin Gel or Combination (Clinical and Histomorphometric Study) Completed NCT03231137 Phase 4 ATV gel
37 Intra-Articular Use of Platelet Rich Plasma Versus Corticosteroid: A Clinical Trials in Osteoarthritis of Knee. Completed NCT03086759 Phase 4 Triamcinolone Hexacetonide
38 Adjunctive Role of Platelets Rich Fibrin in Palatal Wound Healing After Free Gingival Graft Harvesting - Case Series Completed NCT02521467 Phase 4
39 The Effect of Nitrate Supplementation: Source of Supplementation Completed NCT02271633 Phase 4
40 Arthroscopic Rotator Cuff Repair Using Standard Double Row Technique With Platelet Rich Fibrin Membrane vs. Standard Double Row Technique: A Randomized Blinded Outcomes Study Completed NCT02256891 Phase 4
41 A Cohort Study to Evaluate the Effect of Vivostat Platelet Rich Fibrin on Diabetic Foot Ulcers. Completed NCT00770939 Phase 4
42 Regeneration of the Patellar Tendon After Harvesting Its Central Third With Platelet-rich Plasma. Prospective and Randomized Study. Completed NCT01111747 Phase 4
43 Pilot Study: Randomized Controlled Trial on the Influence of an Oral Nutritional Supplement Rich in Omega-3 Fatty Acids on Functional State and Quality of Life in Malnourished Patients With Gastroenterological Tumors Completed NCT00168987 Phase 4 oral nutritional supplement rich in eicosapentanoic acid
44 The Comparison of Knee Osteoarthritis Treatment With Single-dose of Bone Marrow Aspirate Concentrate, Single-dose of Leukocyte Rich Platelet Rich Plasma and 3 Injection of High Molecular Weight Hyaluronic Acid-A Randomized Clinical Trial Completed NCT03825133 Phase 4 Hyaluronic Acid
45 Socket Augmentation Using Atorvastatin With Or Without PRGF Derived Fibrin Scaffold (Clinical and Histomorphometric Study) Completed NCT03228771 Phase 4 PRGF/ATV;ATV gel
46 Effect of Onion Peel Extract on Endothelial Function and Endothelial Progenitor Cells in Overweight and Obese Subjects Completed NCT02180022 Phase 4 Placebo;Onion peel extract
47 Rosuvastatin 1.2mg in Situ Gel Combined With 1:1 Mixture of Autologous Platelet-rich Fibrin and Porus- Hydroxyappatite Bone Graft in Surgical Treatment of Mandibular Degree II Furcation Defects: A Randomized Clinical Control Trial Completed NCT02369250 Phase 4 Rosuvastatin
48 Effect of Undenatured Cysteine-Rich Whey Protein Isolate (HMS 90®) in Patients With Parkinson's Disease: Changes in Biomarkers of Oxidative Stress, Profiles of Plasma Amino Acids and Their Derivatives and Brain Function Completed NCT01662414 Phase 4
49 Efficacy and Safety of the Infiltration of Autologous Plasma Rich in Growth Factors (PRGF) in the Symptomatic Treatment of Knee Osteoarthritis Completed NCT00782197 Phase 4
50 Effect of Eicosapentaenoic Acid (EPA) on Major Cardiovascular Events in Hypercholesterolemic Patients: the Japan EPA Lipid Intervention Study (JELIS) Completed NCT00231738 Phase 4 Eicosapentaenoic acid ethyl ester(EPADEL Capsule 300 TM)

Search NIH Clinical Center for Rapidly Involuting Congenital Hemangioma

Genetic Tests for Rapidly Involuting Congenital Hemangioma

Anatomical Context for Rapidly Involuting Congenital Hemangioma

MalaCards organs/tissues related to Rapidly Involuting Congenital Hemangioma:

41
Bone, Liver, Endothelial, Skin, Breast, Brain, T Cells

Publications for Rapidly Involuting Congenital Hemangioma

Articles related to Rapidly Involuting Congenital Hemangioma:

(show top 50) (show all 30037)
# Title Authors PMID Year
1
Histological Evidence for Therapeutic Induction of Angiogenesis Using Mast Cells and Platelet-Rich Plasma within A Bioengineered Scaffold following Rat Hindlimb Ischemia. 38
31376320 2020
2
The Impact of Metal-Rich Sediments Derived from Mining on Freshwater Stream Life. 38
30671689 2020
3
The use of stromal vascular fraction (SVF), platelet-rich plasma (PRP) and stem cells in the treatment of osteoarthritis: an overview of clinical trials. 38
30887856 2019
4
Thermotolerant cellulolytic Clostridiaceae and Lachnospiraceae rich consortium enhanced biogas production from oil palm empty fruit bunches by solid-state anaerobic digestion. 38
31374416 2019
5
Hydrocarbon rich bio-oil production, thermal behavior analysis and kinetic study of microwave-assisted co-pyrolysis of microwave-torrefied lignin with low density polyethylene. 38
31374414 2019
6
Preoperative vitamin-rich carbohydrate loading alleviates postoperative cognitive dysfunction in aged rats. 38
31340174 2019
7
Effects of hydrogen-rich water on the nutrient composition and antioxidative characteristics of sprouted black barley. 38
31279124 2019
8
High specific MNase assay for rapid identification of Staphylococcus aureus using AT-rich dsDNA substrate. 38
31357354 2019
9
Antioxidants-rich ice cream containing herbal extracts and fructooligossaccharides: manufacture, functional and sensory properties. 38
31276942 2019
10
Phaeodactylum tricornutum microalgae as a rich source of omega-3 oil: Progress in lipid induction techniques towards industry adoption. 38
31253257 2019
11
Effect of dietary fiber-rich fractions on texture, thermal, water distribution, and gluten properties of frozen dough during storage. 38
31253335 2019
12
Synthesis of edge-rich vertical multilayer graphene nanotube arrays towards high-performance supercapacitors. 38
31300621 2019
13
Exploiting the unwanted: Sulphate reduction enables phosphate recovery from energy-rich sludge during anaerobic digestion. 38
31330399 2019
14
Current practices and challenges in using microalgae for treatment of nutrient rich wastewater from agro-based industries. 38
31412448 2019
15
Dissolution of radioactive, cesium-rich microparticles released from the Fukushima Daiichi Nuclear Power Plant in simulated lung fluid, pure-water, and seawater. 38
31195267 2019
16
Non-aerated single-stage nitrogen removal using a down-flow hanging sponge reactor as post-treatment for nitrogen-rich wastewater treatment. 38
31195268 2019
17
The cysteine-rich domain of synaptosomal-associated protein of 23 kDa (SNAP-23) regulates its membrane association and regulated exocytosis from mast cells. 38
31260699 2019
18
Steam gasification of land, coastal zone and marine biomass by thermal gravimetric analyzer and a free-fall tubular gasifier: Biochars reactivity and hydrogen-rich syngas production. 38
31228745 2019
19
Arachidonic acid-rich ARASCO oil has anti-inflammatory and antidiabetic actions against streptozotocin + high fat diet induced diabetes mellitus in Wistar rats. 38
31310962 2019
20
Relevance of N-nitrosation reactions for secondary amines in nitrate-rich wastewater under UV-C treatment. 38
31254883 2019
21
Antimicrobial effects of various platelet rich concentrates-vibes from in-vitro studies-a systematic review. 38
31316893 2019
22
Experimental observation of a negative grey trion in an electron-rich WSe2 monolayer. 38
31272091 2019
23
Bio-regeneration of different rich CO2 absorption solvent via microalgae cultivation. 38
31319210 2019
24
Extraction of soluble sugars from banana puree to obtain a matrix rich in non-starch polysaccharides. 38
31126497 2019
25
In vivo oral bioavailability of Pb sequestered in metal rich granules in bivalves. 38
31202933 2019
26
Carbohydrates-rich corncobs supported metal-organic frameworks as versatile biosorbents for dye removal and microbial inactivation. 38
31320080 2019
27
Preliminary Findings of Platelet-Rich Plasma-Induced Ameliorative Effect on Polycystic Ovarian Syndrome. 38
31210429 2019
28
The value of floc and biofilm bacteria for anammox stability when treating ammonia-rich digester sludge thickening lagoon supernatant. 38
31181494 2019
29
A novel method for evaluating and quantifying cell types in platelet rich fibrin and an introduction to horizontal centrifugation. 38
31148358 2019
30
Enhanced nitrogen removal from nitrate-rich mature leachate via partial denitrification (PD)-anammox under real-time control. 38
31227428 2019
31
In vivo hepatoprotective and In vitro radical scavenging activities of Cucumis ficifolius A. rich root extract. 38
31220599 2019
32
Shotgun proteomic analysis of quinoa seeds reveals novel lysine-rich seed storage globulins. 38
31151615 2019
33
Rich pictures: a companion method for qualitative research in medical education. 38
31037744 2019
34
Effects of platelet-rich plasmapheresis during cardiovascular surgery: A meta-analysis of randomized controlled clinical trials. 38
30708148 2019
35
Nonequilibrium magnetic properties in oxygen-rich LaMnO3 nanoparticles. 38
31108469 2019
36
Med15: Glutamine-Rich Mediator Subunit with Potential for Plasticity. 38
31036407 2019
37
Glycine rich proline rich protein from Sorghum bicolor serves as an antimicrobial protein implicated in plant defense response. 38
31236845 2019
38
Ultrasound shear wave elastography effectively predicts integrity of ventral hernia repair using acellular dermal matrix augmented with platelet-rich plasma (PRP). 38
30547392 2019
39
Bioaugmentation strategy for overcoming ammonia inhibition during biomethanation of a protein-rich substrate. 38
31146133 2019
40
Tannin-rich sainfoin pellet supplementation reduces fat volatile indoles content and delays digestive parasitism in lambs grazing alfalfa. 38
30614428 2019
41
Efficacy of injectable platelet-rich plasma in reducing alveolar bone resorption following rapid maxillary expansion: A cone-beam computed tomography assessment in a randomized split-mouth controlled trial. 38
30920874 2019
42
What Is the Non-calcifying Langerhans Cell-Rich Variant of Calcifying Epithelial Odontogenic Tumor? 38
30284106 2019
43
How to evaluate the cellular uptake of CPPs with fluorescence techniques: Dissecting methodological pitfalls associated to tryptophan-rich peptides. 38
31283917 2019
44
Platelet-rich plasma and its utility in medical dermatology: A systematic review. 38
31009668 2019
45
Nitrogen removal performance of marine anammox bacteria treating nitrogen-rich saline wastewater under different inorganic carbon doses: High inorganic carbon tolerance and carbonate crystal formation. 38
31154281 2019
46
Enhanced nitrogen removal through marine anammox bacteria (MAB) treating nitrogen-rich saline wastewater with Fe(III) addition: Nitrogen shock loading and community structure. 38
31085055 2019
47
Usefulness of platelet-rich fibrin as a hemostatic agent after dental extractions in patients receiving anticoagulant therapy with factor Xa inhibitors: a case series. 38
31102080 2019
48
Leucine-rich α-2-glycoprotein predicts proliferative diabetic retinopathy in type 2 diabetes. 38
31256924 2019
49
Esterified plantain flour for the production of cookies rich in indigestible carbohydrates. 38
31054650 2019
50
Tracking polysaccharides during white winemaking using glycan microarrays reveals glycoprotein-rich sediments. 38
31285016 2019

Variations for Rapidly Involuting Congenital Hemangioma

Expression for Rapidly Involuting Congenital Hemangioma

Search GEO for disease gene expression data for Rapidly Involuting Congenital Hemangioma.

Pathways for Rapidly Involuting Congenital Hemangioma

GO Terms for Rapidly Involuting Congenital Hemangioma

Sources for Rapidly Involuting Congenital Hemangioma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 TGDB
71 Tocris
72 UMLS
73 UMLS via Orphanet
Content
Loading form....